Oracle CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Stuart Levey, EVP, Chief Legal Officer of Oracle Corp, received 523 shares of common stock on July 24, 2026.
NYSE
Oracle's Vice Chairman, Jeffrey Henley, executed a series of stock option exercises and sales totaling over 745,000 shares under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Oracle Corporation Director Stephen Rusckowski was granted 1,550 restricted stock units on May 31, 2026.
NYSE
Oracle Corporation Director Charles Moorman acquired 2,114 shares of common stock through the vesting of restricted stock units.
NYSE
Oracle Corporation director Tomislav Mihaljevic was granted 1,550 restricted stock units as part of standard equity compensation.
NYSE
Oracle Corporation Director Rona Alison Fairhead reported the vesting and settlement of restricted stock units and a subsequent tax-related share withholding.
NYSE
Oracle Corporation Director Bruce R. Chizen acquired 2,114 shares of common stock through the vesting and conversion of restricted stock units.
NYSE
Oracle Corporation Director Michael J. Boskin acquired 2,114 shares of common stock through the vesting of restricted stock units.
NYSE
Oracle Corporation Director Jeffrey Berg exercised restricted stock units and adjusted indirect holdings in a recent SEC filing.
NYSE
Oracle Corporation Director Awo Ablo exercised restricted stock units and withheld shares for tax obligations.
NYSE
Hilary B. Maxson, Chief Financial Officer of Oracle Corp, reported the acquisition of stock options and restricted stock units on May 5, 2026, with vesting schedules extending through 2030.
NYSE
Oracle EVP and Chief Legal Officer Stuart Levey acquired 346.321 restricted stock units via dividend equivalents.
NYSE
Oracle Corporation Executive Vice President and Chief Legal Officer Stuart Levey sold 15,000 shares of common stock on April 16, 2026.
NYSE
Oracle Vice Chairman Jeffrey Henley transferred 745,000 shares of common stock into a newly created grantor retained annuity trust.
NYSE
Oracle Vice Chairman Jeffrey Henley transferred 128,304 shares of common stock from his GRAT to a community property trust, a change in beneficial ownership.
NYSE
Oracle's Chief Executive Officer, Clayton M. Magouyrk, sold 10,000 shares of common stock for approximately $1.55 million in a pre-scheduled transaction.
NYSE
Oracle's EVP, Chief Legal Officer, Stuart Levey, reported the deferral of 337.783 restricted stock unit dividend equivalents.
NYSE
Oracle's EVP and Principal Financial Officer, Douglas A. Kehring, sold 35,000 shares of common stock at $194.89 per share as part of a pre-arranged trading plan.
NYSE
Oracle's President of Global Field Operations, Mark Hura, reported gifting 5,000 shares and selling 15,000 shares of common stock in late December.
NYSE
Oracle Vice Chairman Jeffrey Henley reported a transfer of 199,071 common stock shares between his family trusts, a transaction exempt under SEC Rule 16a-13.
NYSE
Oracle Director Naomi O. Seligman sold 2,223 shares of common stock for $196.61 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Oracle's Chief Executive Officer, Clayton M. Magouyrk, sold 10,000 shares of common stock for approximately $1.92 million under a pre-arranged trading plan.
NYSE
Oracle's EVP, Chief Accounting Officer, Maria Smith, reported the vesting of restricted stock units and subsequent share disposition for tax purposes.
NYSE
Oracle Director Stephen H. Rusckowski was granted 793 restricted stock units, vesting on the first anniversary of the grant date.
NYSE
Oracle Director Jeffrey Berg sold 49,365 shares of common stock for approximately $13.5 million through pre-planned transactions.
NYSE
Oracle's EVP and Principal Financial Officer, Douglas A. Kehring, was granted 60,700 restricted stock units, aligning executive interests with shareholder value.
NYSE
Oracle's Executive Chairman and CTO, Lawrence J. Ellison, was granted 571,286 stock options with an exercise price of $280.07, vesting annually over four years.
NYSE
Oracle's President of Global Field Operations, Mark Hura, was granted 428,465 stock options with an exercise price of $280.07, vesting annually over four years.
NYSE
Oracle Corp. granted 32,135 restricted stock units to Vice Chairman Jeffrey Henley, aligning executive incentives with long-term shareholder value.
NYSE
Oracle's Chief Executive Officer, Safra Catz, was granted 32,135 Restricted Stock Units, which will vest in four equal annual installments.